A 75-Year-Old Female Smoker with Advanced Small-Cell Lung Cancer and Eastern Cooperative Oncology Group Performance Status 2 who Responded to Combination Immunochemotherapy with Atezolizumab, Etoposide, and Carboplatin

Patient: Female, 75-year-old Final Diagnosis: Small cell lung cancer Symptoms: Hemoptysis Medication:— Clinical Procedure: — Specialty: Pulmonology OBJECTIVE: Unusual clinical course BACKGROUND: : Atezolizumab is an immune checkpoint inhibitor used as first-line treatment with carboplatin and etopos...

Descripción completa

Detalles Bibliográficos
Autores principales: Dębczyński, Michał, Mojsak, Damian, Kuklińska, Beata, Mróz, Robert Marek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380397/
https://www.ncbi.nlm.nih.gov/pubmed/35949112
http://dx.doi.org/10.12659/AJCR.936536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380397/
https://www.ncbi.nlm.nih.gov/pubmed/35949112
http://dx.doi.org/10.12659/AJCR.936536

Ejemplares similares